{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:29:22Z","timestamp":1772141362535,"version":"3.50.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1097\/md.0000000000011695","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T20:52:58Z","timestamp":1533243178000},"page":"e11695","source":"Crossref","is-referenced-by-count":13,"title":["Fatal outcome of late-onset angiotensin-converting enzyme inhibitor induced angioedema"],"prefix":"10.1097","volume":"97","author":[{"given":"Jone","family":"Jackeviciute","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidas","family":"Pilvinis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rugile","family":"Pilviniene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-80-20210226","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013\u200aESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"R2-80-20210226","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10557-017-6747-9","article-title":"The treatment effect of an ACE-inhibitor based regimen with perindopril in relation to beta-blocker use in 29,463 patients with vascular disease: a combined analysis of individual data of ADVANCE, EUROPA and PROGRESS trials","volume":"31","author":"Brugts","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"R3-80-20210226","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2017.04.006","article-title":"Angiotensin-converting enzyme inhibitor and other drug-associated angioedema","volume":"37","author":"Stone","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"R4-80-20210226","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4168\/aair.2010.2.3.195","article-title":"Angiotensin-converting enzyme inhibitors and angioedema","volume":"2","author":"S\u00e1nchez-Borges","year":"2010","journal-title":"Allergy Asthma Immunol Res"},{"key":"R5-80-20210226","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ehf2.12161","article-title":"ACE inhibitor-associated intestinal angioedema in orthotopic heart transplantation","volume":"4","author":"Srinivasan","year":"2017","journal-title":"ESC Heart Fail"},{"key":"R6-80-20210226","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/acem.12341","article-title":"American College of Allergy, Asthma & Immunology (ACAAI); Society for Academic Emergency Medicine (SAEM). A consensus parameter for the evaluation and management of angioedema in the emergency department","volume":"21","author":"Moellman","year":"2014","journal-title":"Acad Emerg Med"},{"key":"R7-80-20210226","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/pds.4260","article-title":"Antihypertensive drug associated angioedema: effect modification by race\/ethnicity","volume":"26","author":"Reichman","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R8-80-20210226","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/jch.13097","article-title":"Angiotensin-converting enzyme inhibitor-induced angioedema: a review of the literature","volume":"19","author":"Brown","year":"2017","journal-title":"J Clin Hypertens (Greenwich"},{"key":"R9-80-20210226","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1524-6175.2002.01509.x","article-title":"Current concepts of pharmacotherapy in hypertension: ACE inhibitor-related angioedema: can angiotensin-receptor blockers be safely used?","volume":"4","author":"Sica","year":"2002","journal-title":"J Clin Hypertens (Greenwich"},{"key":"R10-80-20210226","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12245-017-0141-z","article-title":"Angioedema in the emergency department: a practical guide to differential diagnosis and management","volume":"10","author":"Bernstein","year":"2017","journal-title":"Int J Emerg Med"},{"key":"R11-80-20210226","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2332\/allergolint.14-OA-0700","article-title":"Clinical and laboratory characteristics that differentiate hereditary angioedema in 72 patients with angioedema","volume":"63","author":"Ohsawa","year":"2014","journal-title":"Allergol Int"},{"key":"R12-80-20210226","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1865-1380-5-39","article-title":"Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema","volume":"5","author":"Bernstein","year":"2012","journal-title":"Int J Emerg Med"},{"key":"R13-80-20210226","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.amjmed.2007.09.024","article-title":"The spectrum and treatment of angioedema","volume":"121","author":"Temi\u00f1o","year":"2008","journal-title":"Am J Med"},{"key":"R14-80-20210226","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.amjcard.2012.03.034","article-title":"Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors","volume":"110","author":"Makani","year":"2012","journal-title":"Am J Cardiol"},{"key":"R15-80-20210226","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/lary.25821","article-title":"Case-control study evaluating competing risk factors for angioedema in a high-risk population","volume":"126","author":"Kamil","year":"2016","journal-title":"Laryngoscope"},{"key":"R16-80-20210226","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2753.2003.00484.x","article-title":"An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors","volume":"10","author":"Morimoto","year":"2004","journal-title":"J Eval Clin Pract"},{"key":"R17-80-20210226","first-page":"860","article-title":"ACE inhibitor angioedema: a very late presentation","volume":"42","author":"Howarth","year":"2013","journal-title":"Aust Fam Physician"},{"key":"R18-80-20210226","first-page":"244","article-title":"Life-threatening angio-oedema and death associated with the ACE inhibitor enalapril","volume":"97","author":"Cupido","year":"2007","journal-title":"S Afr Med J"},{"key":"R19-80-20210226","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000368404","article-title":"Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting","volume":"165","author":"Craig","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"R21-80-20210226","first-page":"A4449","article-title":"Increasing rate of angiotensin-converting enzyme inhibitor-related upper airway angio-oedema","volume":"59","author":"Holm","year":"2012","journal-title":"Dan Med J"},{"key":"R22-80-20210226","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/lary.22349","article-title":"Management of angiotensin-converting enzyme inhibitor-induced angioedema","volume":"121","author":"Al-Khudari","year":"2011","journal-title":"Laryngoscope"},{"key":"R23-80-20210226","first-page":"333","article-title":"Spanish Study Group on Bradykinin-Induced Angioedema; Grupo Espa\u00f1ol de Estudio del Angioedema mediado por Bradicinina. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin","volume":"21","author":"Caballero","year":"2011","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R24-80-20210226","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1067\/mhn.2000.107515","article-title":"Predictors of airway intervention in angioedema of the head and neck","volume":"123","author":"Zirkle","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R25-80-20210226","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/0194599817737974","article-title":"Pharmacotherapy for angiotensin-converting enzyme inhibitor-induced angioedema: a systematic review","volume":"158","author":"Lawlor","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R26-80-20210226","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jemermed.2017.05.037","article-title":"Novel therapies for angiotensin- converting enzyme inhibitor-induced angioedema: a systematic review of current evidence","volume":"53","author":"Riha","year":"2017","journal-title":"J Emerg Med"},{"key":"R27-80-20210226","first-page":"e972","article-title":"When nothing else works: fresh frozen plasma in the treatment of progressive, refractory angiotensin-converting enzyme inhibitor\u2013induced angioedema","volume":"9","author":"Chaaya","year":"2017","journal-title":"Cureus"},{"key":"R28-80-20210226","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1060028015607037","article-title":"Off-label use of agents for management of serious or life-threatening angiotensin converting enzyme inhibitor-induced angioedema","volume":"50","author":"Culley","year":"2016","journal-title":"Ann Pharmacother"},{"key":"R29-80-20210226","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2500\/ajra.2014.28.3989","article-title":"Life-threatening angioedema induced by angiotensin-converting enzyme inhibitors: characteristics and risk factors","volume":"28","author":"Stauber","year":"2014","journal-title":"Am J Rhinol Allergy"},{"key":"R30-80-20210226","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.anai.2014.09.003","article-title":"Angioedema deaths in the United States, 1979-2010","volume":"113","author":"Kim","year":"2014","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000011695","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:19:22Z","timestamp":1620962362000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201808030-00080"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":29,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000011695","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}